An observational study of adherence to anastrozole in early breast cancer treatment

Exclusion Criteria

• - Recurrence of breast cancer
• - Known hypersensitivity to anastrozole or to any of its excipients
• - Any severe concomitant condition which makes it undesirable for the patient to participate in the trial or which would jeopardize adherence with the trial protocol: Amenorrhea<12 months and a intact uterus; Previous inclusion in the present study; Participation in a other clinical study during the last 30 days·
• - Women who does not agreed to participate the program